Market Overview:
The global genomic data analysis and interpretation market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for precision medicine, rising prevalence of chronic diseases, and growing number of public-private partnerships for genomics research. However, the high cost associated with genomic data analysis and interpretation is expected to restrain the growth of the market during the forecast period. Based on type, the global genomic data analysis and interpretation market is segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, and other genomic platforms. NGS held a dominant position in 2017 owing to its ability to sequence large genomes quickly and accurately. Based on application, research and academic institutions accounted for a major share of the global genomic data analysis and interpretation market in 2017 owing to increased funding for genomics research from government organizations worldwide.
Product Definition:
Genomic data analysis and interpretation is the process of examining genomic data in order to understand the function and organization of genomes. This information can be used to improve our understanding of genetic diseases, develop new therapies, and improve crop yields.
Next-Generation Sequencing (NGS):
Next-generation sequencing (NGS) is a method that enables precise and accurate DNA or RNA sequencing. It is also referred to as high-throughput sequencing, because it allows the generation of many sequence reads in a short period of time. The technology has been rapidly advancing over the past few years, with constant improvements in efficiency and volume. This has led to an increase in its application across various fields such as biotechnology, agriculture & food industry, forensics & crime investigation etc.
Polymerase Chain Reaction (PCR):
Polymerase chain reaction (PCR) is an important tool used in molecular biology for the amplification of DNA. It works by increasing the number of times a specific DNA sequence can be repeated. The process is similar to a mathematical algorithm and requires four key components; polymerase, deoxynucleotide triphosphates (dNTPs), magnesium, and RNA target sequence.
Application Insights:
The research and academic institutions segment dominated the global genomic data analysis and interpretation market in 2017, accounting for over 60% of the revenue share. This is owing to a rising number of research studies that are being conducted at various levels across the globe regarding human health applications from genomics.
For instance, as per an article published by The Scientist in 2018, researchers have found a way to use DNA samples from patients with rare diseases and combine them with genetic information from healthy individuals through genome-wide association studies (GWAS). Such initiatives are expected to increase investment opportunities for companies during the forecast period.
Moreover, contract research organizations perform extensive bioinformatics work on genomic data generated through clinical trials or other sources such as public databases or custom datasets supplied by clients.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increased funding for genomic research, and an increase in sequencing demand. The U.S., which is at the forefront of this industry with major contribution from companies such as Illumina and Roche has fueled growth across this region.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in genomics and data analysis tools
- Growing number of public and private sector initiatives to promote genomic research
- rising investment in life sciences sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Genomic Data Analysis and Interpretation Market Research Report
By Type
Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Genomic Platforms
By Application
Research and Academic Institutions, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, Other End Users
By Companies
x Genomics, Agilent Technologies, ASURAGEN INC, Beijing Genomics Institute (BGI), Genomics, Bio-Rad Laboratories, DNASTAR, F. Hoffmann-La Roche Ltd, Golden Helix, Illumina, Oxford Nanopore Technologies, Pacific Biosciences of California, Partek, QIAGEN N.V., SoftGenetics LLC, Thermo Fisher Scientific Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Genomic Data Analysis and Interpretation Market Report Segments:
The global Genomic Data Analysis and Interpretation market is segmented on the basis of:
Types
Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Genomic Platforms
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research and Academic Institutions, Biotechnology and Biopharmaceutical Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations, Forensic Laboratories, Other End Users
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- x Genomics
- Agilent Technologies
- ASURAGEN INC
- Beijing Genomics Institute (BGI)
- Genomics
- Bio-Rad Laboratories
- DNASTAR
- F. Hoffmann-La Roche Ltd
- Golden Helix
- Illumina
- Oxford Nanopore Technologies
- Pacific Biosciences of California
- Partek
- QIAGEN N.V.
- SoftGenetics LLC
- Thermo Fisher Scientific Inc.
Highlights of The Genomic Data Analysis and Interpretation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Other Genomic Platforms
- By Application:
- Research and Academic Institutions
- Biotechnology and Biopharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Contract Research Organizations
- Forensic Laboratories
- Other End Users
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genomic Data Analysis and Interpretation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genomic data analysis and interpretation is the process of understanding the genetic information contained in a genome. This can involve identifying patterns, analyzing relationships between genes, and predicting how a gene might influence health or disease.
Some of the key players operating in the genomic data analysis and interpretation market are x Genomics, Agilent Technologies, ASURAGEN INC, Beijing Genomics Institute (BGI), Genomics, Bio-Rad Laboratories, DNASTAR, F. Hoffmann-La Roche Ltd, Golden Helix, Illumina, Oxford Nanopore Technologies, Pacific Biosciences of California, Partek, QIAGEN N.V., SoftGenetics LLC, Thermo Fisher Scientific Inc..
The genomic data analysis and interpretation market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genomic Data Analysis and Interpretation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genomic Data Analysis and Interpretation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genomic Data Analysis and Interpretation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genomic Data Analysis and Interpretation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genomic Data Analysis and Interpretation Market Size & Forecast, 2020-2028
4.5.1 Genomic Data Analysis and Interpretation Market Size and Y-o-Y Growth
4.5.2 Genomic Data Analysis and Interpretation Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Next-Generation Sequencing (NGS)
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Microarray
5.2.4 Other Genomic Platforms
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research and Academic Institutions
6.2.2 Biotechnology and Biopharmaceutical Companies
6.2.3 Hospitals and Diagnostic Laboratories
6.2.4 Contract Research Organizations
6.2.5 Forensic Laboratories
6.2.6 Other End Users
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genomic Data Analysis and Interpretation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genomic Data Analysis and Interpretation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Next-Generation Sequencing (NGS)
9.6.2 Polymerase Chain Reaction (PCR)
9.6.3 Microarray
9.6.4 Other Genomic Platforms
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research and Academic Institutions
9.10.2 Biotechnology and Biopharmaceutical Companies
9.10.3 Hospitals and Diagnostic Laboratories
9.10.4 Contract Research Organizations
9.10.5 Forensic Laboratories
9.10.6 Other End Users
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Next-Generation Sequencing (NGS)
10.6.2 Polymerase Chain Reaction (PCR)
10.6.3 Microarray
10.6.4 Other Genomic Platforms
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research and Academic Institutions
10.10.2 Biotechnology and Biopharmaceutical Companies
10.10.3 Hospitals and Diagnostic Laboratories
10.10.4 Contract Research Organizations
10.10.5 Forensic Laboratories
10.10.6 Other End Users
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Next-Generation Sequencing (NGS)
11.6.2 Polymerase Chain Reaction (PCR)
11.6.3 Microarray
11.6.4 Other Genomic Platforms
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research and Academic Institutions
11.10.2 Biotechnology and Biopharmaceutical Companies
11.10.3 Hospitals and Diagnostic Laboratories
11.10.4 Contract Research Organizations
11.10.5 Forensic Laboratories
11.10.6 Other End Users
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Next-Generation Sequencing (NGS)
12.6.2 Polymerase Chain Reaction (PCR)
12.6.3 Microarray
12.6.4 Other Genomic Platforms
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research and Academic Institutions
12.10.2 Biotechnology and Biopharmaceutical Companies
12.10.3 Hospitals and Diagnostic Laboratories
12.10.4 Contract Research Organizations
12.10.5 Forensic Laboratories
12.10.6 Other End Users
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Next-Generation Sequencing (NGS)
13.6.2 Polymerase Chain Reaction (PCR)
13.6.3 Microarray
13.6.4 Other Genomic Platforms
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research and Academic Institutions
13.10.2 Biotechnology and Biopharmaceutical Companies
13.10.3 Hospitals and Diagnostic Laboratories
13.10.4 Contract Research Organizations
13.10.5 Forensic Laboratories
13.10.6 Other End Users
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genomic Data Analysis and Interpretation Market: Competitive Dashboard
14.2 Global Genomic Data Analysis and Interpretation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 x Genomics
14.3.2 Agilent Technologies
14.3.3 ASURAGEN INC
14.3.4 Beijing Genomics Institute (BGI)
14.3.5 Genomics
14.3.6 Bio-Rad Laboratories
14.3.7 DNASTAR
14.3.8 F. Hoffmann-La Roche Ltd
14.3.9 Golden Helix
14.3.10 Illumina
14.3.11 Oxford Nanopore Technologies
14.3.12 Pacific Biosciences of California
14.3.13 Partek
14.3.14 QIAGEN N.V.
14.3.15 SoftGenetics LLC
14.3.16 Thermo Fisher Scientific Inc.
